Clients & Case Studies
Our Work
Case Studies
$60K → $7.5M
Increased Claim Value
Hospital Opioid
Many large health system clients were planning on filing the Quick Pay option in the Hospital Opioid settlement, which would have paid each hospital a flat recovery of $5,000 without any data provided by the hospital. Once CAC analyzed the value that could be obtained by providing data and articulated the difference to the health system, CAC's data team worked with the clients to submit comprehensive Model option claims. One health system ended up getting a $7,500,000 refund, as opposed to the $60,000 they would have received by continuing with the Quick Pay option.
160%
Increase in available data
BCBS Subscribers
In the Blue Cross Blue Shield (“BCBS”) Subscribers class action, claim value is based on a company's premiums and administrative fees paid to BCBS over the class period. The data the administrator identified and attributed to our corporate clients was believed to be significantly incomplete. Class Action Capital conducted research to find other sources of proof of premiums/admin fees paid, created a tool to extract and analyze the documentation en masse, and worked with the administrator to get the alternative documentation approved. This external data source provided support for premiums/fees 160% higher than the administrator's data, and 84% higher than the client's data.
300%
Increase in award amount
Lovenox & Enoxaparin Class Action
A large healthcare services client was a class member in the Lovenox & Enoxaparin Class Action. The client believed the best course of action was to file a claim using the data available to them and considered working with an outside law firm. The class period in this case spanned 9 years, and the client's data retention policy forced them to purge records prior to a certain period. CAC used internal filing methods to create a comprehensive claim, increasing the client's award amount by 300%.
70%
Increase in claim value
Lithium-Ion Battery Settlement
The Lithium-Ion Battery Settlement was unique for hospitals because of the seemingly unlimited scope of products included—products containing lithium-ion batteries—and the 11-year class period. CAC presented research to the administrator and as a result, our clients had claims accepted when they may have otherwise been worth nothing due to a lack of data. Based on our analysis, our clients received a 70% increase in claim value.
6×
Increase in claim value
EpiPen Antitrust Settlement
Hospitals purchasing EpiPens for operational use initially fell outside the defined class structure in the EpiPen Antitrust Settlement, creating a risk that their claims would be deemed ineligible. Many clients also lacked data covering the full class period or records for recently acquired subsidiaries. CAC identified a filing strategy to address both issues, securing eligibility for hospital operational purchases and reconstructing claim data where gaps existed. Clients who worked with CAC recovered approximately six times more than they would have otherwise; we were likely the only firm to execute this approach.
$4.3M
Increase in award amount
Sutter Health Self-Insured Settlement
Our client is a large company with a self-insured health plan and 11,000 employees in California during the class period for the California Sutter Health Settlement. The settlement administrator told claimants that they had the requisite data from the defendant to calculate claim amounts. When presented with our client's filing details, they claimed that none of their employees received care at eligible facilities, so our client was ineligible to recover from the settlement fund. CAC knew this was illogical and did extensive research which we took back to the settlement administrator. We were able to recover $4.3 million for our client. Our analysis identified over $110 million in healthcare costs eligible within the parameters of the settlement.
Top Client Industries
Automotive
Antitrust and price-fixing cases in the vehicle space are among the most frequent. Companies that bought fleets, parts, or vehicles in volume are often eligible without realizing it, and because purchasing is spread across departments, those high-value claims routinely go unfiled.
Media & Advertising
Advertisers have been swept into antitrust settlements tied to ad markets and platform pricing practices. This sector sees comparatively few filed claims relative to how heavily companies spend on advertising, largely because ad spend spread across agencies, vendors, and internal teams is easy to lose track of, causing many affected businesses to miss their filing windows
Healthcare
Healthcare is impacted by a high volume of class actions spanning pharmaceutical and device pricing, antitrust conduct, and data privacy, producing both frequent mid-size recoveries and outlier opportunities across a wide range of claim sizes. Because health systems maintain such a large number of separate vendor relationships and transactions, recoveries tend to build from many individual claims rather than a few large ones. That volume, combined with decentralized purchasing, makes eligible claims easy to overlook and complex to document, even when the recovery is significant.
Fortune 500
The largest companies show up in nearly every category of settlement, from antitrust to data privacy to supply-chain matters, and often in several at once. A single enterprise can carry both high-value and high-volume claims at the same time. But spending spread across business units and global operations means the records needed to substantiate a claim are rarely centralized, so substantial recoverable funds regularly go unclaimed.
Partnerships
CAC’s Strategic Partnerships program connects us with leading associations and similar organizations to provide their members with streamlined access to our class action recovery services. With 30+ active partnerships in place, this collaboration creates mutually beneficial value by helping organizations support their members while earning referral fees for successful engagements.